Eyepoint Pharmaceuticals Inc (EYPT) earnings · rev $31.4M
These earnings events as JSON? API free 100/dayEyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
This EYPT earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported EYPT revenue for 2025-12-31 was $31.4M. Net income was -$232.0M. Revenue was down 27.5% from 2024-12-31 to 2025-12-31. EYPT currently screens at market cap $1.10B.
When the next EYPT 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 27.5% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full EYPT research stays on the stock page; the tape stays on the quote page.
EYPT earnings FAQ
What are EYPT's latest revenue and net income?
Latest cached Eyepoint Pharmaceuticals Inc (EYPT) revenue for Dec 31, 2025 was $31.4M. Net income was -$232.0M. Statements: https://lician.com/financials/eypt
What is EYPT's latest diluted EPS?
Latest cached Eyepoint Pharmaceuticals Inc (EYPT) diluted EPS for Dec 31, 2025 was -$3.17.
What period does the latest EYPT earnings print cover?
The latest cached Eyepoint Pharmaceuticals Inc (EYPT) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did EYPT revenue change from the prior cached period?
Cached Eyepoint Pharmaceuticals Inc (EYPT) revenue was down 27.5% from $43.3M (Dec 31, 2024) to $31.4M (Dec 31, 2025). Statements: https://lician.com/financials/eypt
Where are EYPT earnings listed?
Cached earnings facts for Eyepoint Pharmaceuticals Inc (EYPT) are listed at https://lician.com/earnings/eypt. Statements: https://lician.com/financials/eypt
Not investment advice.